Miladi R, Janbakhsh A, Babazadeh A, Aryanian Z, Ebrahimpour S, Barary M, Sio TT, Wollina U, Goldust M, Mohseni Afshar Z. Pustular psoriasis flare-up in a patient with COVID-19.
J Cosmet Dermatol 2021;
20:3364-3368. [PMID:
34619013 PMCID:
PMC8661619 DOI:
10.1111/jocd.14508]
[Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2021] [Revised: 08/17/2021] [Accepted: 09/24/2021] [Indexed: 12/14/2022]
Abstract
INTRODUCTION
The various cutaneous manifestations have lately appeared in the setting of COVID-19. Psoriasis flare-ups have been reported during a COVID-19 infection.
CASE PRESENTATION
We present a case of a 32-year-old woman with COVID-19 who presented with generalized pustular psoriasis. She received oral prednisolone, hydroxyzine, and topical clobetasol. The patient received follow-up two weeks later and found that her lesions were favorably desquamating.
METHODS
The PubMed, SCOPUS, and ISI Web of Science databases were thoroughly searched for English studies reporting psoriasis flare-ups following SARS-CoV-2 infection. Ten case reports/series were included after screening.
CONCLUSIONS
Our case report brings awareness to clinicians for the possible cutaneous manifestation of COVID-19, which should be considered part of the differential diagnoses.
Collapse